Gene Mutation-Related Cancer
7
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Genetic Information Assistant in Telegenetics
COsegregation of VARiants in Panel of Genes
Radiomics for prEdiction of lunG cAncer biologY
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Genomic Study of Relapse Esophageal Cancer After Radiotherapy
Study on the Correlation Between Gene Mutation and TCM Syndrome Types in Metastatic Colorectal Cancer